These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29125105)

  • 41. Use of a current varicella vaccine as a live polyvalent vaccine vector.
    Murakami K; Mori Y
    Vaccine; 2016 Jan; 34(2):296-298. PubMed ID: 25444800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine.
    Loparev VN; Rubtcova E; Seward JF; Levin MJ; Schmid DS
    J Infect Dis; 2007 Feb; 195(4):502-10. PubMed ID: 17230409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.
    Mitra M; Faridi M; Ghosh A; Shah N; Shah R; Chaterjee S; Narang M; Bhattacharya N; Bhat G; Choudhury H; Kadhe G; Mane A; Roy S
    Hum Vaccin Immunother; 2015; 11(2):443-9. PubMed ID: 25692656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review of the Varilrix varicella vaccine.
    Chiu SS; Lau YL
    Expert Rev Vaccines; 2005 Oct; 4(5):629-43. PubMed ID: 16221065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentiation between vaccine and wild-type varicella-zoster virus genotypes by high-resolution melt analysis of single nucleotide polymorphisms.
    Toi CS; Dwyer DE
    J Clin Virol; 2008 Sep; 43(1):18-24. PubMed ID: 18479962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The varicella-zoster virus immediate-early 62 promoter contains a negative regulatory element that binds transcriptional factor NF-Y.
    Moriuchi H; Moriuchi M; Cohen JI
    Virology; 1995 Dec; 214(1):256-8. PubMed ID: 8525624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.
    Levin MJ; DeBiasi RL; Bostik V; Schmid DS
    J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cycling probe technology to quantify and discriminate between wild-type varicella-zoster virus and Oka vaccine strains.
    Ihira M; Higashimoto Y; Kawamura Y; Sugata K; Ohashi M; Asano Y; Yoshikawa T
    J Virol Methods; 2013 Nov; 193(2):308-13. PubMed ID: 23820238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.
    Bernstein HH; Rothstein EP; Watson BM; Reisinger KS; Blatter MM; Wellman CO; Chartrand SA; Cho I; Ngai A; White CJ
    Pediatrics; 1993 Dec; 92(6):833-7. PubMed ID: 8233746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
    Reisinger KS; Brown ML; Xu J; Sullivan BJ; Marshall GS; Nauert B; Matson DO; Silas PE; Schödel F; Gress JO; Kuter BJ;
    Pediatrics; 2006 Feb; 117(2):265-72. PubMed ID: 16452343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Genetic characterization of varicella zoster virus in Jilin province in 2014, China].
    Wu QH; Wang S; Cong XL; Zhou JH; Cui AL; Xu WW; Xu ST
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Aug; 50(8):738-42. PubMed ID: 27539529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of a recombinant human gelatin as a substitute for a hydrolyzed porcine gelatin in a refrigerator-stable Oka/Merck live varicella vaccine.
    Liska V; Bigert SA; Bennett PS; Olsen D; Chang R; Burke CJ
    J Immune Based Ther Vaccines; 2007 Feb; 5():4. PubMed ID: 17319952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
    Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
    J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.
    Uebe B; Sauerbrei A; Burdach S; Horneff G
    Eur J Pediatr; 2002 Aug; 161(8):442-4. PubMed ID: 12172829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Oka varicella vaccine as a novel vaccine vector].
    Shiraki K; Suzuki M
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():340-4. PubMed ID: 16615495
    [No Abstract]   [Full Text] [Related]  

  • 58. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Varicella vaccine: genesis, efficacy, and attenuation.
    Arvin AM
    Virology; 2001 Jun; 284(2):153-8. PubMed ID: 11384215
    [No Abstract]   [Full Text] [Related]  

  • 60. Disseminated varicella infection caused by varicella vaccine strain in a child with low invariant natural killer T cells and diminished CD1d expression.
    Banovic T; Yanilla M; Simmons R; Robertson I; Schroder WA; Raffelt NC; Wilson YA; Hill GR; Hogan P; Nourse CB
    J Infect Dis; 2011 Dec; 204(12):1893-901. PubMed ID: 22043019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.